Interleukins as Mediators of the Tumor Cell—Bone Cell Crosstalk during the Initiation of Breast Cancer Bone Metastasis

Patients with advanced breast cancer are at high risk of developing bone metastasis. Despite treatment advances for primary breast cancer, metastatic bone disease remains incurable with a low relative survival. Hence, new therapeutic approaches are required to improve survival and treatment outcome...

Descripción completa

Detalles Bibliográficos
Autores principales: Haider, Marie-Therese, Ridlmaier, Nicole, Smit, Daniel J., Taipaleenmäki, Hanna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7999500/
https://www.ncbi.nlm.nih.gov/pubmed/33809315
http://dx.doi.org/10.3390/ijms22062898

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7999500/
https://www.ncbi.nlm.nih.gov/pubmed/33809315
http://dx.doi.org/10.3390/ijms22062898

Ejemplares similares